After a six-year wait, the world’s largest Genomics and Biodata event is making its highly anticipated return to Boston! Join […]
Marine organisms are expected to be an important source of inspiration for drug discovery. At present, very few databases exist […]
A recent Nature review, describes the latest developments in the use of machine learning approaches to interrogate datasets in neurodegenerative […]
D4 Pharma is delighted to announce the launch of D4 Global: the world’s first truly global event focusing on data-driven […]
Introduction: Single-cell sequencing technology has been advanced by the falling sequencing costs, a boom in microfluidics and combinatorial indexing strategies. […]
With the advent of high-throughput techniques, we have a greater capability than ever before to study a diverse range of […]
In his keynote presentation at D4 in Basel last October, Philippe Marc, Global Head Integrated Data Sciences at Novartis, set […]
A recent study has explored the concept of a modern and collaborative approach to data-driven drug development called Translational Precision […]
It is widely known that the traditional drug discovery and development process is extremely time-consuming, expensive and challenging; taking an […]
Here we summarise a recent review article, published in Neuroimaging Clinics, that explored the additive value of artificial intelligence (AI) […]
